Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Search Press releases


CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum05 Aug 2020

CIMZIA[®] is the First and Only Biologic Approved in Europe …

Read more
Acquisitions and disposals of own shares30 Jul 2020

Acquisitions and disposals of own shares

Read more
Transparency notification FMR LLC.30 Jul 2020

Transparency notification FMR LLC.

Read more
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease29 Jul 2020

UCB enters into collaboration with Roche to develop antibody treatment …

Read more
UCB Half Year Report 2020: UCB’s resilient product portfolio drives continued company growth27 Jul 2020

UCB Half Year Report 2020: UCB’s resilient product portfolio …

Read more
Disposals of own shares24 Jul 2020

Disposals of own shares

Read more


Stay up-to-date on the latest news and information from UCB